EQUINE PROTOZOAL MYELOENCEPHALITIS


Bibliography

Works referenced or cited

Animal Health Pharmaceuticals, LLC, "Freedom of Information Summary NADA 141-240, REBALANCE Antiprotozoal Oral suspension."  November 5, 2004.
Open Rebalance Freedom of Information
Summary PDF

Bayer Corporation, "Freedom of Information Summary NADA 141-188, Marquis Antiprotozoal Oral Paste."
Open Marquis Freedom of Information Summary PDF

Bello, Thomas R., and Tammy Allen. "The Use of MicroLactin for Inflammatory Conditions in Equine Veterinary Practice." Journal of Equine Veterinary Science 25 (2005): 380-82. Elsevier. <http://www.sciencedirect.com>.

Bello, Thomas R., and Tammy K. Allen. "An Intensive Approach in the Treatment of Clinical Equine Protozoal Myeloencephalitis." Journal of Equine Veterinary Science 28 (2008): 479-483. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Bello, Thomas R., "Review of 'An Intensive Approach' article and protocol."  Telephone intrview, April 2009.

Bents, B., et. al. "Seroprevalence of antibodies to Sarcocystis neurona in equids residing in Oklahoma", J Vet Diagn Invest, 15:597-600 (2003)
Open PDF by clicking here

Bolton, K. E., and Et Al. "Sarcocystis neurona: Molecular characterization of enolase domain I region and a comparison to other protozoa." Experimental Parasitology 120 (2008): 108-12. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Crowdus, Carolyn A., and et al. “SnSAG5 is an alternative surface antigen of Sarcocystis neurona strains that is mutually exclusive to SnSAG1.”  Veterinary Parasitology 158 (2008):36-43.  Elsevier.  3 Mar. 2009 <http://www.sciencedirect.com.>

Duarte, P., et. al. "Comparison of a serum indirect fluorescent antibody test with two Western blot tests for the diagnosis of equine protozoal myeloencephalitis." J Vet Diagn Invest 15:8–13 (2003)
Open PDF by clicking here

Elsheikha, Hany M. "What Makes Sarcocystis neurona So Special?" Journal of Equine Veterinary Science 27 (2007): 99-100. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

"Equine Meds List." Franck's Pharmacy. 24 Feb. 2009 <https://secure.francks.com/docs/equine_med_list.pdf>. 

Finno, C., et. al. "Effects of blood contamination of cerebrospinal fluid on results of indirect fluorescent antibody tests for detection of antibodies against Sarcocystis neurona and Neospora hughesi". J Vet Diagn Invest 19:286–289 (2007)
Open PDF by clicking here

Furr, Martin. "Immunity, Pathophysiology, and Diagnosis of Equine Protozoal Myeloencephalitis." Clinical Techniques in Equine Practice 5 (2006): 3-8. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Gaji, Rajshekhar Y., and Et Al. "The heptanucleotide motif GAGACGC is a key component of a cis-acting promoter element that is critical for SnSAG1 expression in Sarcocystis neurona." Molecular and Biochemical Parasitology Unpub (2009). Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Gargala, G. et. al., "In vitro efficacy of nitro- and halogen-thiazolide/thiadiazolide derivatives against Sarcocystis neurona."  J Vet Para.2009.03.022.  28 Mar. 2009.  Elsevier. <http://www.sciencedirect.com>

Howe, Daniel K., and Et Al. "Strains of Sarcocystis neurona exhibit differences in their surface antigens, including the absence of the major surface antigen SnSAG1." International Journal for Parasitology 38 (2008): 623-31. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

IDEXX Pharmaceuticals, Inc., "Freedom of Information Summary NADA 141-178, Navigator Antiprotozoal Oral Paste."  November 18, 2003.
Open Navigator Freedom of Information Summary PDF 

Jouany, J.P., et. al., “Effect of live yeast culture supplementation on apparent digestibility and rate of passage in horses fed a high-fiber or high-starch diet.”  Journal of Animal Science 86 (2008): 339-47.  PubMED. 8 Mar. 2009 http://jas.fass.org/cgi/content/full/86/2/339

Lindsay, David S., and Et Al. "Penetration of equine leukocytes by merozoites of Sarcocystis neurona." Veterinary Parasitology 138 (2006): 371-76. Elsevier. <http://www.sciencedirect.com>.

MacKay, Robert J.  "Equine Protozoal Myeloencephelitis: Managing Relapses."  Compendium Equine Jan/Feb 2008.  IntegraConnect.  6 Mar. 2009
Click here to open pdf.

MacKay, Robert J. "Equine Protozoal Myeloencephalitis: Treatment, Prognosis, and Prevention." Clinical Techniques in Equine Practice 5 (2006): 9-16. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

May, Dr. “New Bolton CSF Tap, SAG1 ELISA Questions, and IFAT information.”  Telephone interview.  Feb, 2009.

The Merck Veterinary Manuel. Feb. 2009 < http://www.merckvetmanual.com/mvm/index.jsp>.

Mitchell, Mark A. "Ponazuril." Journal of Exotic Pet Medicine 17 (2008): 228-29. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Morley, P. S., and Et Al. "Risk Factors for Owner-Reported Occurrence of Equine Protozoal Myeloencephalitis in the US Equine Population." Journal of Veterinary Internal Medicine: 22 (2008): 616-29. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Morresey, Peter R. "Management of the Acutely Neurologic Patient." Clinical Techniques in Equine Practice 5 (2006): 104-11. 3 Mar. 2009 <http://www.sciencedirect.com>.

Mullaney, Thomas, and Et Al. "Evidence to support horses as natural intermediate hosts for Sarcocystis neurona." Veterinary Parasitology 133 (2005): 27-36. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Norton, Dr. "New Bolton Study of EPM serum and CSF tests." Telephone interview. Feb. 2009.

Reed, Stephen M.  "Neurology Is Not a Euphemism for Necropsy: A Review of Selected Neurological Diseases Affecting Horses."  AAEP Proceedings, (2008) Vol 54. <http://www.ivis.org/proceedings/aaep/2008/P11121.1208.pdf>

Reed, Stephen M. "Unusual symptoms of EPM in Charlie Brown." Telephone interview. March 2005.  

Respondek, F., and Et Al. "Effects of dietary short-chain fructooligosaccharides on the intestinal microflora of horses subjected to a sudden change in diet." Journal of Animal Science 86 (2008): 316-23.  PubMed. 8 Mar. 2009 http://jas.fass.org/cgi/content/full/86/2/316

Rossano, M. G., and Et Al. "Parasitemia in an immunocompetent horse experimentally challenged with Sarcocystis neurona sporocysts." Veterinary Parasitology 127 (2005): 3-8. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Schering-Plough Animal Health Corp., "Freedom Of Information Summary NADA 141-268, Protazil Antiprotozoal Pellets."  March 29, 2007.
Open Protazil Freedom of Information Summary PDF

The Horse: Your Guide to Equine Health Care, on-line edition, various articles 01/01/2004 to present.  http://thehorse.com  search terms: epm, symptoms, diagnosis, treatment, alternative medicine, probiotics, diclazuril, ponazuril, toltrazuril, herbs, opossum, wobblers, EHV1, tetnus, rabies, and many more.

"US Patent 5883095 - Formulations and methods to treat and prevent equine protozoal myeloencephalitis." Patent Storm. Feb. 2009 <http://www.patentstorm.us/patents/5883095/fulltext.html>.

"US Patent 6344337 - Antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid." Patent Storm. Feb. 2009 <http://www.patentstorm.us/patents/5883095/fulltext.html>.

Yang, Jibing, and Et Al. "Immune response to Sarcocystis neurona infection in naturally infected horses with equine protozoal myeloencephalitis." Veterinary Parasitology 138 (2006): 200-10. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>.

Zhang, Deqing, and Et Al. "Investigation of SnSPR1, a novel and abundant surface protein of Sarcocystis neurona merozoites." Veterinary Parasitology 152 (2008): 210-19. Elsevier. 3 Mar. 2009 <http://www.sciencedirect.com>. 

Note:  Most veterinary journals were accessed from www.elsevier.com.  As of May 2009, the web site links have been changed to www.sciencedirect.com